Abstract
The level of cognitive impairment in patients with bipolar affective disorder (BD) represents a topic of general interest because it is essential when talking about treatment adherence, quality of life, and global burden of disease. Of the treatments currently available for BD, the most studied mood stabilizer is lithium. The mechanisms and effects that lithium has on cognition are not well known. This study aims to review the current knowledge regarding the levels of impairment or improvement of cognition induced by lithium in patients with BD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
